Evidence map›Paper›PMID 33717426›Full record

ArticleTherapeutic advances in chronic disease2021

Decreased numbers and sex-based differences of circulating regulatory T cells in patients with seropositive undifferentiated arthritis.

Hong-Qing Niu, Chenrui Yuan, Chenglan Yan, Na Li, Yuan-Sheng Lei, Xuxu Li, Jinli Ru, Xiao-Feng Li

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in chronic disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hong-Qing NiuDepartment of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.ORCID https://orcid.org/0000-0002-9823-7334
Chenrui YuanDepartment of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chenglan YanDepartment of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Na LiDepartment of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Yuan-Sheng LeiDepartment of Neurology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Xuxu LiDepartment of General Practice, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Jinli RuDepartment of General Practice, The Second Hospital of Shanxi Medical University, 382 Wuyi Road, Taiyuan, Shanxi 030001, China.
Xiao-Feng LiDepartment of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Shanxi Medical University · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsCD4

methodsPeripheral blood samples and clinical information were collected from 177 patients with SUA, 104 patients with RA, and 120 healthy controls. All patients were newly diagnosed and untreated. Proportions and absolute counts of CD4

resultsIn patients with SUA, percentages and absolute counts of circulating regulatory T (Treg) cells were decreased significantly and Th17/Treg cell ratios were abnormally increased, whereas Th17 cell numbers were similar to those in healthy controls. In addition, sex-based differences in circulating Treg cells were observed, with female SUA patients having lower proportions and absolute counts of Treg cells than those in males. Moreover, female patients with SUA had higher erythrocyte sedimentation rates and 28-joint Disease Activity Scores than those in males.

conclusionImmune tolerance deficiency resulting from an abnormal reduction in circulating Treg cells might be the most crucial immunological event in the earliest stage of RA. The sex-specific disparity in Treg cells should also be considered for immunoregulatory and preventive strategies targeting early RA.

Indexed as

immune toleranceregulatory T cellsrheumatoid arthritisseropositive undifferentiated arthritis

Identifiers

PMID33717426
PMCPMC7925950
OpenAlexW3129565050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.